Gene: KCNH3
Official Full Name: potassium voltage-gated channel subfamily H member 3provided by HGNC
Gene Summary: The protein encoded by this gene is a voltage-gated potassium channel alpha subunit predominantly expressed in the forebrain. Studies in mice have found that cognitive function increases when this gene is knocked out. In humans, the encoded protein has been shown to be capable of binding glycoprotein 120 of the human immunodeficiency virus type 1 (HIV-1) envelope. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29319 | KCNH3 Knockout cell line (HCT 116) | Human | KCNH3 | 1:2~1:4 | Negative | Online Inquiry |
KO29320 | KCNH3 Knockout cell line (A549) | Human | KCNH3 | 1:3~1:4 | Negative | Online Inquiry |
KCNH3 Gene Knockout Cell Lines are meticulously engineered cellular models in which the KCNH3 gene, associated with coding for potassium channels, has been systematically disrupted to eliminate its expression. These cell lines serve as vital tools for investigating the physiological and pathological roles of the KCNH3 gene, particularly in relation to various ion channel-related disorders.
The primary function of KCNH3 involves encoding potassium ion channels that are instrumental in maintaining the electrical excitability of neurons and other cell types. By knocking out this gene, researchers can observe alterations in cellular behavior, including changes in membrane potential, ionic flow, and downstream signaling pathways. This enables a deeper understanding of the gene's involvement in conditions such as epilepsy, cardiac arrhythmias, and other neuromuscular diseases.
From a scientific perspective, KCNH3 Gene Knockout Cell Lines are invaluable in both research and clinical settings. In research, they facilitate drug screening and the development of novel therapeutics aimed at correcting dysregulated ionic currents. Clinicians can utilize findings from studies employing these cell lines to target specific pathways implicated in ion channel pathologies, thus aiding in personalized medicine approaches.
Compared to alternative systems such as wild-type cell lines, KCNH3 Knockout Cell Lines uniquely provide a controlled environment to study the absence of gene expression effects without confounding factors. This specificity enhances experimental rigor and increases confidence in the generated data, often leading to more robust conclusions.
For researchers and clinicians alike, these knockout cell lines offer a gateway to unraveling complex cellular mechanisms, driving innovation in therapeutic strategies, and potentially translating discoveries into clinical applications. Our commitment to excellence in producing high-quality biological products, backed by a team of experts in genetic engineering and cell biology, ensures that KCNH3 Gene Knockout Cell Lines meet the rigorous demands of the scientific community. Harness the power of targeted gene functionality to advance your research and clinical endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.